Amlodipine reduces blood pressure and hadache fquency in cocaine-dependent outpatients

Journal of Psychoactive Drugs

Volumn 34, Issue 4, 2002, Pages 415-419

  Malcolm, Robert ^a   Liao, Jason ^a   Michel, Melissa ^a   Cochran, Kristina ^a   Pye, Wesley ^a   Yeager, Derik ^a   Halushka, Perry V ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Amlodipine; Blood pressure; Calcium channel antagonists; Cocaine dependence; Headaches

Indexed keywords

AMLODIPINE; PLACEBO; RIBOFLAVIN;

ADULT; ANALGESIA; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; BRAIN BLOOD VESSEL; CLINICAL ARTICLE; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; EVALUATION; FAINTNESS; FEMALE; HEADACHE; HUMAN; HYPERTENSION; MALE; PERIPHERAL EDEMA; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; VERTIGO;

ADULT; AMLODIPINE; BLOOD PRESSURE; CHI-SQUARE DISTRIBUTION; COCAINE-RELATED DISORDERS; DOUBLE-BLIND METHOD; FEMALE; HEADACHE; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; POISSON DISTRIBUTION;

EID: 0036823487     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.2002.10399983     Document Type: Article

References (32)

1. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, D.C.: American Psychiatric Press.
2. Anton, R.F. 1996. New methodologies for pharmacologic treatment trials for alcohol dependence. Alcoholism, Clinical and Experimental Research 20: 3A-9A.
3. Arrunda, J.A.L.; Kurtzmann, N.A. & Pillay, V.K.G. 1975. Prevalence of renal disease in asymptomatic heroin addicts. Archives of Internal Medicine 135: 535-37.
4. Bainbridge, A.D.; Herliby, O.; Meredith, P.A. & Elliot, H.L. 1993. A comparative assessment of amlodipine and felodipine ER: Pharmacokinetics and pharmacodynamic indices. European Journal of Clinical Pharmacology 45 (5): 425-30.
5. Brecklin, C.S.; Gopaniuk-Folga, A.; Kravetz, T.; Sabah, S.; Singh, A.; Arrunda, J.A.L. & Dunea, G. 1998. Prevalence of hypertension in chronic cocaine users. American Journal of Hypertension 11: 1279-83.
6. Calcagnetti, D.J.; Keck, B.J.; Quatrella, L.A. & Schechter, M.D. 1995. Blockade of cocaine-induced conditioned place preference: Relevance to cocaine abuse therapeutics. Life Sciences 56 (7): 474-83.
7. Carroll, K.M.; Rounsaville, B.J. & Keller, D.S. 1991. Relapse prevention strategies for the treatment of cocaine abuse. American Journal of Drug Alcohol Abuse 17 (3): 249-65.
8. Clavijo, G.A.; Clavijo. I.V. and Weart. C.W. 1994. Amlodipine: A new calcium antagonist. American Journal of Hospital Pharmacy 51 (1): 59-68.
9. Dhopesh, V.; Maanym, I. & Herring, C. 1991.Therelationship of cocaine to headache in polysubstance abusers. Headache 31 (I): 17-19.
10. Dunea, G.; Arruda, J.A.; Bakir, A.A.; Share, D.S. and Smith. E.C. 1995. Role of cocaine in end-stage renal disease in some hypertensive African Americans. American Journal of Nephrology 15 (1): 5-9.
11. el-Mallakh, R.S.; Kranzler, H.R. & Kamanitz, J.R. 1991. Headaches and psychoactive substance use. Headaches 31 (9): 584-87.
12. Faulkner, J.K.; McGibney, D.; Chasseaud, L.F.; Perry, J.L. & Taylor, I. W. 1986. The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily. British Journal of Clinical Pharmacology 22 (I): 21-25.
13. He, G.Q.; Zhang, A.; Altura, B.T. & Altura, B.M. 1994. Cocaine-induced cerebrovascular spasm and its possible mechanisms of action. Journal of Pharmacology and Experimental Therapeutics 268: 1532-39.
14. Holman, B.L.; Mendelson, J.; Garada, B.; Teoh, S.K.; Hallgring, E.; Johnson, K.A. & Mello, N.K. 1993. Regional cerebral blood flow improves with treatment in chronic cocaine polydrug abusers. Journal of Nuclear Medicine 34 (5): 723-27.
15. Johnson, B.; Barron, B.; Fang, B.; Lamki, L.; Wagner, L.; Wells, L.; Kenny, P.; Overton, D.; Dhother, S.; Abramson, D.; Chen, R. & Kramer, L. 1998. Isradipine prevents global and regional cocaine-induced changes in brain blood flow: A preliminary study. Psychopharmacology 136: 335-41.
16. Johnson, B.A.; Devous, M.D., Sr.; Ruiz, P. & Ait-Daoud, N. 2001. Treatment advances for cocaine-induced ischemic stroke: Focus on dihydropyridine-class calcium channel antagonists. American Journal of Psychiatry 158: 1191-98.
17. Kaufman, M.J.; Levin, J.M.; Ross, M.H.; Lange, N.; Rose, S.L.; Kukes, T.J.; Mendelson, J.H.; Lukas, S.E.; Cohen, B.M. & Renshaw, P.F. 1998. Cocaine-induced cerebral vasoconstriction detected in humans with magnetic resonance angiography. Journal of the American Medical Association 279 (5): 376-80.
18. Kosten, T.R. 1998. Pharmacotherapy of cerebral ischemia in cocaine dependence. Drug and Alcohol Dependence 49: 133-44.
19. Lange, R.A. & Hillis, L.D. 2001. Cardiovascular complications of cocaine use. New England Journal of Medicine 345: 351-58.
20. Levine, S.R.; Brust, J.C.; Futrell, N.; Brass, L.M.; Blake, D.; Fayad, P.; Schultz, L.R.; Millikan, C.H.; Ho, K.L. & Welch, K.M. 1991. A comparative study of the cerebrovascular complications of cocaine: Alkaloidal versus hydrocholoride C, a review. Neurology 41 (8): 1173-77.
21. Lipton, R.B.; Choy-Kwong, M. & Solomon, S. 1989. Headaches in hospitalized cocaine users. Headache 29 (4): 225-28.
22. Malcolm, R.; Brady, K.T.; Moore, J. & Kajdasz, D. 1999. Amlodipine treatment of cocaine dependence. Journal of Psychoactive Drugs 31 (2): 117-20.
23. Meredith, P.A. & Elliot, H.L. 1992. Clinical pharmacokinetics of amlodipine. Clinical Pharmacokinetics 22 (I): 22-31.
24. Mo, W.; Arruda, J.A.; Dunea, G. & Singh, A.K. 1999. Cocaine-induced hypertension: Role of the peripheral sympathetic system. Pharmacological Research 40 (2): 139-45.
25. Mo, W.; Singh, A.K.; Arruda, J.A. & Dunea, G. 1998. Role of nitric oxide in cocaine-induced acute hypertension. American Journal of Hypertension II (6 Pt I): 708-14.
26. Poon, J. & van den Buuse, M. 1998. Autonomic mechanisms in the acute cardiovascular effects of cocaine in conscious rats. European Journal of Pharmacology 363: 147-52.
27. Saper, J.R. 1989. Migraine, migraine variants, and related headaches. Otolaryngologic Clinics of North America 22 (6): 1115-30.
28. Schiffrin, E.L. 1998. Vascular protection with newer antihypertensive agents. Journal of Hypertension 16 (5): S25-29.
29. Strickland, T.L.; Mena, l.; Villanueva-Meyer, J.; Miller, B.L.; Cummings, J.; Mehringer, C.M.; Satz, P. & Meyers, H. 1993. Cerebral perfusion and neuropsychological consequences of chronic cocaine use. Journal of Neuropsychiatry and Clinical Neurosciences 5 (4): 419-27.
30. Thakur, V.; Godley, C.; Weed, S.; Cook, M.E. & Hoffman, E. 1996. Case reports: Cocaine-associated accelerated hypertension and renal failure. American Journal of the Medical Sciences 312 (6): 295-98.
31. Varrone, J. 1991. A study of the efficacy and safety of amlodipine for the treatment of hypertension in general practice. Postgraduate Medical Journal 67 (Suppl 5): S28-S31.
32. Volkow, N.D.; Hitcemann, R.; Faller, J.S.; Dewey, S. & Hoff, A. 1991. Regional brain metabolic activity during different stages of cocaine withdrawal. Journal of Nuclear Medicine 32: 960.